MAT1A and metabolic dysfunction-associated steatohepatitis: In sum, mice lacking Mat1a secrete less VLDL-TG and show impaired mitochondrial function, increased ROS, and reduced FA β-oxidation, GSH content, and PC/PE molar ratio and the development of NASH and fibrosis.